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Abstract
Human Papillomavirus (HPV) is the most common sexually transmitted infection in
the U.S and can lead to several types of cancers. A better understanding of the
variables impacting HPV vaccination will help inform the development of effective
disease prevention interventions. This study aims to describe factors that impact
parents’ and caregivers’ decisions to vaccinate their children against HPV by
examining sociocultural factors and behavioral change theory among parents or
caretakers of sons and daughters (ages 9-18) from diverse socioeconomic, racial, and
ethnic backgrounds. A national sample was recruited and participants completed
demographic questions and measures related to their attitudes and beliefs about the
vaccine and measures based on the transtheoretical model. These variables were used
to predict child vaccine initiation and to validate existing measures using a novel
sample. Health care provider recommendation, perceived vaccine effectiveness, pros
for vaccination, and self-efficacy increased the likelihood that children had initiated
the HPV vaccine. While no significant differences were found for race/ethnicity and
gender on vaccine initiation, some disparities were noted. There were regional
differences in perceived cons for vaccination, socioeconomic differences in selfefficacy and perceived effectiveness, and gender differences in health care provider
recommendation and parent perception of cons, vaccine harm, and barriers. These
findings may inform future, tailored interventions aimed at increasing HPV vaccine
initiation among children and adolescents.
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Introduction
Human papillomavirus (HPV) is the most common sexually transmitted
infection (STI) and high-risk types can cause cancer (Baseman & Koutsky, 2005).
Cervical cancer rates are higher in Black and Latina communities (National Cancer
Institute, 2011; Ward et al., 2004). Disparities in uptake of the HPV vaccine will
further perpetuate disparities in cancer rates. Health related behaviors are often
influenced by sociocultural factors. A better understanding of the variables impacting
HPV vaccination will help inform the development of effective disease prevention
interventions. This study aims to describe differences in HPV vaccine uptake among
parents or caretakers of sons and daughters (ages 9-18) from diverse socioeconomic,
racial, and ethnic backgrounds. Racial/ethnic disparities, beliefs and perceptions about
the vaccine, barriers to obtaining the vaccine, gender differences, health behavior
change variables, and parent-child communication about vaccination and sexual health
will be examined.
Human Papillomavirus and Vaccination
HPVs are a group of viruses that infect the skin and mucous membranes. There
are over 100 different types of HPV and more than 40 of these types are transmitted
sexually. HPV is the most common STI in the U.S. (National Cancer Institute, 2013).
The highest rates of HPV infection are found among sexually active individuals
between the ages of 15-24 and in the U.S., over 14 million people contract a new HPV
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infection every year (American Cancer Society, 2013). High-risk HPV types can cause
cervical, vaginal, vulvar, anal, penile, and head/neck cancers. High-risk types are
responsible for about 70% of cervical cancers (de Sanjose et al., 2010), almost all anal
cancers, 40% of penile cancers, and 25-35% of oral cancers (Parkin & Bray, 2006;
Watson et al., 2008). Low-risk HPV types cause cervical cell changes and cause 90%
of genital warts (Gerend & Barley, 2009). The majority of HPV infections are
asymptomatic and clear without medical intervention. However, around 10% of
women who contract “high risk” HPV will develop persistent infections that can cause
cervical cancer (Ault, 2006).
In 2006, the Food and Drug Administration approved Gardasil®, a vaccine that
helps protect against the HPV types that are responsible for 70% of cervical cancer. It
is recommended for males and females aged 9-26 years old (Centers for Disease
Control and Prevention, 2006; Center for Disease Control and Prevention, 2011).
Gardasil is a three dose vaccine series administered over six months. The Advisory
Committee on Immunization Practices recommends universal vaccination of all 11-12
year old children as vaccination is preferable before sexual debut to optimize the
protective benefits. However, “catch-up” vaccination of individuals aged 13-26 is also
recommended (Dempsey, Gebremariam, Koutsky & Manhart, 2008).
A national survey found that only 28.9% of girls aged 11-17 years had
received at least 1 dose of the vaccine and that only 14.2% had received all 3 doses
(Laz, Rahman, & Berenson, 2012). Currently, less is known about vaccine uptake
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among males. Using national samples, two studies found that in the first year after
licensure, only 1-2% of adolescent boys had received at least 1 dose of the vaccine
(Reiter, McRee, Kadis, & Brewer, 2011; Center for Disease Control and Prevention,
2011). Finding ways to increase vaccine uptake are very important. A recent study
found a 56% decrease in vaccine type HPV prevalence among a nationally
representative sample of females 14-19 years old in the vaccine era (2007-2010) when
compared with the prevaccine era (2003-2006) (Markowitz et al., 2013).
Racial/Ethnic disparities
In the U.S., cervical cancer incidence and mortality rates are higher in Black
women than White women (National Cancer Institute, 2011). Rates of cervical cancer
among African-American women remain 39% higher than among White women
(American Cancer Society, 2011). In addition, cervical cancer mortality rates are more
than twice as high among African-American women as among White women.
Similarly, when compared with White women, age-adjusted cervical cancer incidence
rates are 80% higher among Latinas (Ward et al., 2004). Universal HPV vaccination
could potentially reduce racial and ethnic disparities in cancer prevalence and
mortality. Unfortunately, those most at risk for vaccine-preventable disease are
generally the least likely to obtain them, such as Latinos (Mays, Stru, & Zimet, 2004).
Awareness of HPV and HPV vaccination appear to be quite high. Jain and
colleagues (2009) found that 84.3% of the women they surveyed (aged 18-49) had
3

heard of HPV and 78% of the women had heard of the HPV vaccine. However,
awareness varied by racial/ethnic group, education level and insurance coverage.
Black women and Hispanic women were less likely to be aware of the vaccine
compared to non-Hispanic white women. Many disparities remain largely
unexplained. Due to the age recommendation for vaccination, psychosocial variables
among parents and care givers should be further examined.
Predictors of parents’ acceptance and intention to vaccinate
Several studies have examined predictors of HPV vaccine adoption. Wong and
colleagues (2011) found that parental education of less than high school level, wellchild check and influenza shot in the past year, and parental familiarity with the HPV
vaccine were associated with higher vaccine uptake among girls ages 9-17 years.
Another study describing HPV vaccination among adolescent girls in high-risk
communities found that parent awareness of the vaccine, belief in vaccine
effectiveness, and doctor recommendation were positively associated with vaccine
initiation. They also found that negative attitudes toward the vaccine and needing
more information about the vaccine were negatively associated with vaccine initiation
(Guerry et al., 2011). Brewer and colleagues (2011) found that rates of vaccine
initiation were higher among parents who perceived lower barriers to getting the
vaccine, anticipated greater regret if their daughters got HPV and were not vaccinated,
or were not born-again Christians.
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Acceptance of the vaccine appears to be high in many communities. Bair,
Mays, Sturm, and Zimet (2008) found that acceptance of the HPV was high in a
sample of Latina mothers. They found that the reasons for not accepting the vaccine
included a lack of information and feeling that their daughters were too young. Pierre
Joseph and colleagues (2012) found that African-American mothers were more
knowledgeable and accepting of the HPV vaccine than Haitian Immigrant mothers.
Most African-American mothers felt that vaccination fell within the parental role,
whereas most Haitian mothers felt uncomfortable vaccinating against STIs as they felt
children should not be sexually active and reported discomfort discussing sex.
Providers should focus on providing information about the rationale for vaccination in
early adolescence and vaccine safety as they could potentially play a role in opening
discussions about the protection that vaccination would provide, while remaining
culturally sensitive.
Physician recommendation appears to be an extremely important predictor of
vaccine uptake and may also play a role in vaccine disparity. Litton and colleagues
(2011) did not find race, education, religion, knowledge, or perceived susceptibility to
be significantly associated with intention to vaccinate their daughter in a sample of
racially diverse caregivers from Alabama. However, they did find that the caregivers
who were informed by their health care providers about the vaccine were more likely
to vaccinate their adolescent daughters. Hamlish, Clarke, and Alexander (2012)
examined motivators and barriers to HPV vaccination among African-American
5

mothers. They found that the mothers trusted physicians to initiate discussion of HPV
vaccination and those physicians who failed to initiate the discussion generated doubt
about the vaccine among the mothers. Ylitalo, Lee, and Mehta (2013) examined
national data and found that when adolescents were provided with a health care
provider recommendation for vaccination they were almost 5 times as more likely to
receive the vaccine than those without a recommendation. This association between
recommendation and vaccination appeared strong across all racial/ethnic groups;
however, they found that racial/ethnic minorities were less likely to receive a
recommendation. Further, Polonij and Carpiano (2013) found that the odds of
receiving a recommendation were negatively associated with SES and black racial
status.
Gender differences
Mothers appear to show more willingness to vaccinate daughters. Linddon,
Hood, Wynn, and Markowitz (2010) conducted a literature review and found that
among mothers of sons, support of HPV vaccination varied widely from 12% to
100%. They also found that a preference to vaccinate females over males was reported
in a majority of studies. This appeared to be due to the belief that the vaccine would
not directly benefit males. A recent study found similar results, women with only a
daughter were more willing than those with a son to vaccinate their child (71% vs
44%), mothers of both daughters and sons were more willing to vaccinate their
daughters (67% vs 39%), and mothers of sons as compared to daughters were less
6

likely to consider their child at risk of HPV (27% vs 12%) (Berenson & Rahman,
2012).
Gilkey, Moss, McRee, and Brewer (2012) found that among sons, initiation of
HPV vaccine was lower for those living in high income households and higher for
those whose race was neither white nor black. Parents of unvaccinated sons were more
likely than those of daughters to report not getting a physician’s recommendation or
not being aware that the vaccine was available for their son. Factors such as perceived
benefit of HPV vaccine appear to differ by child’s gender, it is important to continue
filling in gaps in the literature by examining gender differences among parents in their
intention to vaccinate their children against HPV.
Most studies examining adolescent HPV vaccine uptake surveyed mothers or
female caregivers only. However, some studies surveyed male and female caregivers
(Brewer, et al, 2011; Guerry et al., 2011; Gilkey et al., 2012). Among these studies,
most respondents were female (between 88-91%). Attitudes and beliefs about HPV
vaccination among both male and female caregivers should be further explored to
identify potential differences across gender.
Parent Communication about sex and vaccination
Parent-child communication about sex is associated with decreased sexual risk
taking during adolescence and an older age at sexual debut (DeClemente et al., 2001;
Miller et al., 1998). Parents should have conversations about sex early for them to be
7

most effective. Communication about sex should ideally begin before children begin
having sex (Miller et al., 1998). However, parents often underestimate their child’s
level of sexual activity. Beckett and colleagues (2010) found that 40% of youth had
intercourse before their parents talked with them about safe sex. Additionally, Latina
and Asian mothers have been found to be less likely to discuss sex with their
daughters when compared to Black and White mothers (Meneses, Orrell-Valente,
Guendelman, Oman, & Irwin, 2006). Many parents rely on situations that arise
spontaneously to prompt conversations with their children about safe sex. External
cues, such as a child’s sex education class can prompt parents to initiate conversations
about sex (Rosenthal, Feldman, & Edwards, 1998; O’Sullivan, Meyer-Bahlburg, &
Watkins, 2001).
Discussions about the vaccine may provide parents with an opportunity to talk
with their children about STIs and safe sex. Communication about the HPV vaccine
has been examined as a potential cue for mother-daughter communication about sex.
McRee and colleagues (2012) found that 65% of mothers reported talking with their
daughters about the HPV vaccine, of whom 41% reported that led to a conversation
about sex. Mothers who talked with their daughters about HPV vaccination were more
likely than those who had not to have also talked with them about sex (92% vs. 74%).
Among the mothers who talked about sex when they talked about HPV vaccination,
many felt that the vaccine provided a good reason to talk about sex (64%) or that it
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made it easier to start the conversation (33%). To date, no study has examined the
relationship between parent-son communication about sex and the HPV vaccine.
Transtheoretical Model
The Transtheoretical Model (TTM) is an integrated and comprehensive model
of behavioral change (Prochaska & Velicer, 1997). The TTM describes intentional
behavior change through a series of five stages that result in long-term maintenance of
the behavior: Precontemplation, Contemplation, Preparation, Action and Maintenance
(Naar-King et al., 2006). These stages have been used to look at readiness to obtain
the vaccine among college women. The TTM provides an integration of processes and
principles of change from different theories, including Janis and Mann’s (1977) model
of decision making and Bandura’s (1977) construct of self-efficacy (Schumann et al.,
2005).
The TTM has been validated for many health-related behaviors including
smoking, mammography screening and increasing condom use (Levy, 1997). When
TTM constructs mentioned above are combined using validated measures, tailored
interventions can be developed to target behavioral change. TTM measures of selfefficacy and decisional balance for HPV vaccination were validated among college
women (Lipschitz et al., 2013). These measures were developed to examine a
participants’ confidence in their ability to complete the vaccine series and to measure a
participants’ pros and cons for receiving the vaccine. TTM-tailored interventions are a
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promising option to increase vaccination. Before developing an intervention for
caregivers, TTM measures should be validated within this unique population.
Brief interventions have been shown to be effective in increasing
understanding of HPV and increasing positive attitudes towards vaccination in adult
women (Doherty & Low, 2008). By gaining a better understanding of the variables
that predict vaccine adoption among children and adolescents, interventions can be
created and aimed at increasing vaccination at earlier ages. Interventions should be
based on health behavior change theory in order to reach parents at different stages of
change. Demographic variables should be considered to develop culturally competent
interventions. Parent-child communication about sex and vaccination should be
examined to develop better ways to promote safer sex.
The purpose of the current study is to examine differences in HPV vaccine
uptake and parent-child communication about sex among parents/caregivers and their
children. Predictors of HPV vaccination in a sample of diverse parents/caregivers will
also be examined. The study extends previous research in several ways. Both parent
and child demographics, parent attitudes and beliefs about the HPV vaccine, TTM
variables, and parent-child communication about sex will be examined to determine
whether they add unique variance in the prediction of vaccination. These variables will
be used to predict the likelihood of falling into one of the two categories (vaccine
initiated vs. vaccine uninitiated). The initiated group will be defined as having begun
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the vaccine series (the series is contained within three shots: baseline, 2 months and 6
months). Specifically it is expected that:
Hypothesis 1: When parents/caregivers have received a health care provider’s
recommendation, their child will be more likely to have initiated the vaccine
series.
Hypothesis 2: When parents perceive the vaccine as effective, their child will
be more likely to have initiated the vaccine series, as measured by the CHIAS
effectiveness subscale.
Hypothesis 3: When parents perceive the vaccine to be potentially harmful,
their child will be less likely to have completed the vaccine series, as measured
by the CHIAS harms subscale.
Hypothesis 4: When parents perceive barriers to vaccination, their child will
be less likely to have initiated the vaccine series, as measured by the CHIAS
barriers subscale.
Hypothesis 5: When parents feel uncertain about the vaccine, their child will
be less likely to have initiated the vaccine, as measured by the CHIAS
uncertainty subscale.
Hypothesis 6: Given the findings related to racial/ethnic differences in vaccine
adoption rates, the percent initiating the vaccine series will differ by
11

racial/ethnic group. Racial and ethnic minorities will be less likely to have
initiated the vaccine series.
Hypothesis 7: Given the findings related to gender differences in vaccine
adoption rates, female children will be more likely to have initiated the vaccine
series.
Hypothesis 8: Given the findings related to gender differences in vaccine
uptake rates, among parents who haven’t initiated the vaccine, those with sons
will be less willing to initiate vaccination as they may perceive that
their sons are less likely to benefit from the vaccine when compared to
parents of daughters.
Hypothesis 9: Parents who talked to their child about HPV vaccination will be
more likely than those who had not to have also talked with them about safe
sex, as measured by the UNC Mother-Daughter Survey.
Hypothesis 10: In accordance with the TTM’s decisional balance construct, the
children of parents who have more pros and fewer cons for receiving the HPV
vaccination will be more likely to have initiated the vaccine series, as
measured by the Decision Balance for HPV scale.
Hypothesis 11: The children of those parents who have more vaccine selfefficacy (i.e., higher confidence) will be more likely to have initiated the
vaccine series, as measured by the Self-efficacy for HPV scale.
12

Hypothesis 12: When all significant variables are looked at together, TTM
variables (decisional balance, self-efficacy) will be the strongest predictors of
HPV vaccine initiation.
Hypothesis 13: TTM measures of decisional balance and self-efficacy will be
validated in a population of male and female parents/caregivers.
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Method
Participants
Parents and caregivers were recruited using Survey Sampling International
(SSI) and informal recruitment (i.e., emailing colleagues) using an online survey. A
total of 335 participants began the online survey. However, 26 were removed from the
data set because they indicated that they were not a parent or caregiver of a child
between the ages of 9-18 during the initial screening question. Another 16 participants
were removed from the data set as they quit before they completed the demographic
questions. A total of 292 participants were included in the final data set.
Measures
Demographic questions. The online questionnaire presented to participants
included a series of demographic questions about the participants and their children
including: gender, race/ethnicity (white, non-white), age, sexual orientation, country
of origin, current state and region in which they reside (South, Northeast, Midwest,
West), highest level of education (four years of college or more, some college, high
school diploma/GED or less), household income (under $25,000, $25,000-$50,000,
$50,000-$75,000, $75,000 or more, choose not to answer), and various questions
about their child’s vaccination status. Participants with more than one child between
the ages of 9-18 were asked to think about their child that had the most recent birthday
when answering the questions.
14

Decisional Balance for HPV vaccination. Developed by Lipschitz and
colleagues (2011), the Decisional Balance scale is an 8-item questionnaire measuring
the Pros and Cons of completing the vaccine series. Four items represent the Pros of
receiving the vaccine series and four items represent the Cons of receiving the vaccine
series. An example of a Pros item is “Protecting my child from HPV would make me
feel good”. An example of a Cons item is “Receiving the series of three shots would
take too much time”. The items are measured using a 5-point Likert scale ranging
from 1 = ‘Not Important’ to 5 = ‘Extremely Important’. Responses are summed for the
Pros items and the Cons items separately, producing two continuous predictor
variables. Higher scores represent higher perceptions for the pros and cons variables.
According to the authors, internal consistency is good for the Pros scale (α=0.90) and
adequate for the Cons scale (α=0.66). In the current study, the Cronbach alpha
coefficient was good for the Pros scale (α=0.86) and the Cons scale (α=.88).
Self-Efficacy for HPV vaccination. Developed by Lipschitz and colleagues
(2011), the Self-Efficacy scale is a 6-item questionnaire aimed at measuring
participants’ confidence in their ability to complete the vaccine series in situations that
may prove challenging. An example of an item is “When I think about the possible
side effects of the vaccine”. Items are measured on a 5-point Likert scale, ranging
from 1=”Not at All Confident” to 5=”Extremely Confident.” All items are summed
producing a continuous predictor variable. Higher scores represent higher perceptions
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for self-efficacy. According to the authors, internal consistency is good (α=0.84). In
the current study, the Cronbach alpha coefficient was good (α=.89).
The Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS).
Developed by McRee and colleagues (2010), the CHIAS is a 16-item questionnaire
aimed at measuring a range of parent attitudes and beliefs about HPV vaccine. The
authors identified four CHIAS subscales, all of which had acceptable scale alphas and
one-year test-retest reliability. An example of an item from the Perceived Harms
subscale is “The HPV vaccine might cause short term problems, like fever or
discomfort”. The items are measured using a 4-point Likert scale ranging from 1=
‘Strongly Disagree’ to 4= ‘Strongly Agree’. Responses are reverse scored and
summed for each subscale, producing four continuous predictor variables. Higher
scores represent higher perceptions of Perceived Harm, Barriers, Effectiveness, and
Uncertainty. According to the authors, the subscales include Perceived Potential
Harms of HPV vaccination (α=.69), Perceived Barriers to vaccination (α=.69),
Perceived Effectiveness of HPV vaccination (α=.61), and Uncertainty about HPV
vaccination (α=.66). In the current study, the Cronbach alpha coefficient was good for
Perceived Potential Harms (α=.84), Perceived Barriers (α=.92), Perceived
Effectiveness (α=.83), and adequate for Uncertainty (α=.45).
UNC Mother-Daughter Communication Survey. Developed by McRee and
colleagues (2009), the mother-daughter communication survey is based on established
measures in the literature (Miller et al., 2009) as well as HPV vaccine research
16

involving parents of adolescent girls (Reiter, et al., 2009; McRee et al., 2011). The
survey assesses mother-daughter communication about sex, mother-daughter
communication about HPV vaccination, and other potential cues to talking about sex.
Questions were reworded to include sons and fathers. An example of an item is “I
think that my child should wait until he/she is married to have sex”. Some items are
measured using a 5-point Likert scale, ranging from 1=’Strongly Disagree’ to
5=’Strongly Agree’. Other items are measured with a ‘Yes’ or ‘No’. Individual items
were used to examine parent-child communication about HPV vaccination and safe
sex.
Procedure
Parents and caregivers were recruited using SSI and informal recruitment
using an online survey. SSI is a global provider of sampling solutions for survey
research and data collection and provided recruitment of national data. National data
was census balanced for race/ethnicity and geographical region. Only parents and
caregivers of children or adolescents between the ages of 9-18 were eligible for this
study as Gardasil® is only recommended for children starting at age 9. Participants
recruited through SSI earned points for completing the survey which could be
exchanged for small prizes. Informally recruited participants were not offered any
incentive for completing the survey. Following Institutional Review Board approval,
participants completed the survey via SurveyMonkey.com. The participants were first
given Informed Consent to Participate in Research and brief instructions. All
17

responses were kept anonymous to protect participant’s privacy. Following that, the
survey began and participants were asked to try to complete all of the included
questions.
Data Analysis
Descriptive statistics were run to examine outliers, means, standard deviations,
skewness, kurtosis, frequencies, and correlations among variables. A series of
independent-samples t-tests, one-way ANOVAs, and chi-squares were run to explore
demographic group differences across TTM and CHIAS variables. Logistic regression
analysis was conducted to examine the likelihood of falling into one of the two
outcome categories (initiated vaccine vs. did not initiate vaccine) given the categorical
and continuous predictor variables described in hypotheses 1-12. A confirmatory
factor analysis (CFA) was used to validate the use of the TTM measures within this
sample of parents and caregivers. Missing data as well as preliminary assumption
testing were assessed. All analyses were performed using IBM SPSS v. 22 and EQS.
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Results
Description of the Sample
The final sample was composed of 292 parents and caregivers between the
ages of 27 and 64 (M=40.67, SD=7.94). The participants identified as White (69.9%),
Latino/Latina (11.6%), Black/African American (11%), Asian (4.8%), American
Indian (1.4%), Native Hawaiian or Pacific Islander (.3%), and Other (1%). The modal
participant identified as a mother (63%), heterosexual (93.5%), married (77.4%), had a
4-year degree or higher (52%), had an estimated household income of 75,000 or
higher (45.9%), were born in the United States (89.7%), were currently living in the
northeast (35.3%), and had two children (38%). The children were between nine and
18 years old (M =12.38, SD =3.08). The modal child described by participants was
female (54.1%), White (66.4%), had not completed the HPV vaccine series (64.7%),
and had not started the vaccine series (50.3%). Complete demographic information for
the sample are presented in Table 1.
Exploratory Analyses
Descriptive statistics for the TTM and CHIAS measures are shown in Table 2.
Exploratory analyses were run to examine demographic group differences in
vaccination, TTM variables, and attitudes and beliefs about HPV vaccination (see
Tables 3 and 4).
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Demographics differences on TTM, CHIAS, vaccine completion, vaccine
initiation, and health care provider recommendation.
Parent Race. There were no significant differences in scores for race/ethnicity
on the TTM variable scores (pros, cons, self-efficacy) or CHIAS (perceived harm,
barriers, effectiveness, uncertainty) scores. Additionally, there was no significant
association between race/ethnicity and vaccine completion, initiation, or health care
provider recommendation.
Child Gender. There was a significant difference in cons for vaccination
series between male children (M=52.47, SD=10.73) and female children (M=47.85,
SD=8.83); t (289) = -4.039, p= .000, two-tailed. There was a significant difference in
CHIAS perceived harm for vaccination scores between male children (M=51.24,
SD=10.31) and female children (M=48.85, SD=9.58); t (288) = -2.044, p= .042, twotailed. There was a significant difference on CHIAS barriers for vaccination scores
between male children (M=52.50, SD=10.89) and female children (M=47.89,
SD=8.69); t (288) = -3.94, p= .000, two-tailed. There were no significant differences
in scores for child gender on the pros, self-efficacy, effectiveness, or uncertainty
scores. A Chi-square test for independence (with Yates Continuity Correction)
indicated that there was a significant association between child gender and health care
provider recommendation, χ² (1, n= 273) = 6.43, p=.011, phi=-.161. There was no
significant association between child gender and vaccine completion or initiation.
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Parent Gender. There was a significant difference in uncertainty for
vaccination scores between male parents (M=52.51, SD=10.10) and female parents
(M=48.82, SD=9.75); t (289) = -2.76, p= .003, two-tailed. There were no significant
differences in scores for parent gender on TTM variables or perceived harm, barriers,
or effectiveness for vaccination scores. A Chi-square test for independence (with
Yates Continuity Correction) indicated that there was a significant association
between parent gender and vaccine initiation, χ² (1, n= 292) = 4.37, p=.037, phi=.130
and parent gender and vaccine completion, χ² (1, n= 292) = 4.092, p=.043, phi=.126.
There was no significant association between parent gender and health care provider
recommendation.
Parent Education. ANOVA revealed mean scores on the self-efficacy
measure differed significantly by parent’s level of education, F(2, 289)=4.202, p=.016.
No significant group differences were found between parent education and pros, cons,
or CHIAS variables. There was no significant association between parent education
and vaccine completion, initiation, or health care provider recommendation.
Geographical Region. The ANOVA showed mean scores on the cons measure
differed significantly by region, F(3, 288)=2.886, p=.036. No significant group
differences were found between region and pros, self-efficacy, or CHIAS variables.
There was no association between region and vaccine completion, initiation, or health
care provider recommendation.

21

Household income. The ANOVA showed mean scores on the perceived
effectiveness measure differed significantly by household income, F(4, 279)=3.12,
p=.016. Mean scores on the uncertainty measure also differed significantly by
household income, F(4, 279)=3.52, p=.008. No significant differences were found
between household income on TTM variables or perceived harm or barriers.
Hypothesis Testing
Hypothesis 1: When parents/caregivers have received a health care
provider’s recommendation, their child will be more likely to have initiated the
vaccine series. A logistic regression analysis was performed to assess the relationship
between health care provider recommendation and child vaccine initiation (received at
least one shot in the series). The model contained health care provider
recommendation as the independent variable (0=no health care provider
recommendation; 1=health care provider recommendation). The ‘odds ratio’ for
recommendation was 11.73 with a 95% confidence interval of [6.63-20.75], p < .000.
This suggests that those who were recommended be their health care provider are
almost 12 times more likely to initiate the vaccine compared to those who did not
receive the recommendation (see Table 5).
Hypothesis 2: When parents perceive the vaccine as effective (as measured
by the CHIAS effectiveness subscale), their child will be more likely to have
initiated the vaccine series. A logistic regression analysis was performed to assess
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the relationship between parent’s perception of vaccine effectiveness and child
vaccine initiation. The model contained vaccine effectiveness as the continuous
independent variable. The ‘odds ratio’ for perceived effectiveness was 1.08 with a
95% confidence interval of [1.05-1.11], p<.000. This suggests that for each one unit
increase in perceived vaccine effectiveness, the children were 8% more likely to have
initiated the vaccine series (see Table 5). The range for this scale was 2-8, so
participants with a score of 3 are 8% more likely to have initiated the vaccine
compared to participants with a score of 2.
Hypothesis 3: When parents perceive the vaccine to be potentially harmful
(as measured by the CHIAS perceived harm subscale), their child will be less
likely to have completed the vaccine series. A logistic regression analysis was
performed to assess the relationship between parent’s perception of potential harm
caused by the vaccine and child vaccine initiation. The model contained potential
harm as the continuous independent variable. The ‘odds ratio’ for perceived harm was
.96 with a 95% confidence interval of [.936-.982], p<.001. This suggests that for each
one unit increase in perceived harm, the children were 4% less likely to have initiated
the vaccine series (see Table 5). The range for this scale was 6-24, so participants
with a score of 7 are 4% less likely to have initiated the vaccine compared to
participants with a score of 6.
Hypothesis 4: When parents perceive barriers to vaccination (as
measured by the CHIAS perceived barriers subscale), their child will be less
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likely to have initiated the vaccine series. A logistic regression analysis was
performed to assess the relationship between parent’s perception of barriers to
vaccination and child vaccine initiation. The model contained perceived vaccine
barriers as the continuous independent variable. The ‘odds ratio’ for perceived barriers
was 1.04 with a 95% confidence interval of [1.02-1.06], p<.003. This suggests that for
each one unit increase in perceived vaccine barriers, the children were 4% more likely
to have initiated the vaccine series (see Table 5). The range for this scale was 5-20, so
participants with a score of 6 are 4% more likely to have initiated the vaccine
compared to participants with a score of 5.
Hypothesis 5: When parents feel uncertain about the vaccine (as measured
by the CHIAS uncertainty subscale), their child will be less likely to have
initiated the vaccine. A logistic regression analysis was performed to assess the
relationship between parent’s feelings of uncertainty about the vaccine and child
vaccine initiation. The model contained uncertainty as the continuous independent
variable. The ‘odds ratio’ for uncertainty was .97 with a 95% confidence interval of
[.95-1.00], p=.076, and was not statistically significant. This suggests that the model
was not able to distinguish between respondents who reported and did not report
vaccine initiation (see Table 5).
Hypothesis 6: Given the findings related to racial/ethnic differences in
vaccine adoption rates, the percent initiating the vaccine series will differ by
racial/ethnic group. Racial and ethnic minorities will be less likely to have
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initiated the vaccine series. Logistic regression analysis was performed to assess the
relationship between race and ethnicity and child vaccine initiation. The model
contained race (0=white; 1=non-white) as the independent variable. The ‘odds ratio’
for race was 1.24 with a 95% confidence interval of [.75-2.05], p=.40, and was not
statistically significant. The second model contained ethnicity (0=non-Latino;
1=Latino) as the independent variable. The ‘odds ratio’ for ethnicity was 1.16 with a
95% confidence interval of [.57-2.37], p=.684, and was not statistically significant.
These results suggest that the model was not able to distinguish between respondents
who reported and did not report vaccine initiation (See Table 5).
Hypothesis 7: Given the findings related to gender differences in vaccine
adoption rates, male children will be less likely to have initiated the vaccine
series. A logistic regression analysis was performed to assess the relationship between
child’s gender and child vaccine initiation. The model contained child gender
(0=female; 1=male) as the independent variable. The ‘odds ratio’ for gender was 1.37
with a 95% confidence interval of [.87-2.18], p=.178, and was not statistically
significant. This suggests that the model was not able to distinguish between
respondents who reported and did not report vaccine initiation (See Table 5).
Hypothesis 8: Given the findings related to gender differences in vaccine
uptake rates, among parents who haven’t initiated the vaccine, those with sons
will be less willing to initiate vaccination as they may perceive that their sons are
less likely to benefit from the vaccine when compared to parents of daughters. A
25

logistic regression was performed to assess the relationship between child gender and
stage of change. The model contained child gender (0=male; 1=female) as the
independent variable and Stage of Change (0=Precontemplation and Contemplation
collapsed; 1=Preparation) as the dependent variable. The ‘odds ratio’ for gender was
1.2 with a 95% confidence interval of [.60-2.4], p=.577, and was not statistically
significant. This suggests that the model was not able to distinguish between
respondents who were in Precontemplation/Contemplation and Preparation (See Table
5).
Hypothesis 9: Parents who talked to their child about HPV vaccination
will be more likely than those who had not to have also talked with them about
safe sex, as measured by the UNC Mother-Daughter Survey. A logistic regression
analysis was performed to assess the relationship between parents talking to their child
about the HPV vaccine and parents also talking to their child about safe sex topics.
The model contained HPV discussion (0=did not talk to child about HPV; 1=did talk
to child about HPV) as the independent variable. The ‘odds ratio’ for discussing HPV
vaccination was 2.90 with a confidence interval of [1.90-4.42], p<.000. This suggests
that those who discussed HPV vaccination with their child were almost three times
more likely to have also discussed safe sex (see Table 5).
Hypothesis 10: In accordance with the TTM’s decisional balance
construct, the children of parents who have more pros and fewer cons for
receiving the HPV vaccination will be more likely to have initiated the vaccine
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series, as measured by the Decision Balance for HPV scale. A logistic regression
analysis was performed to assess the relationship between pros and cons for receiving
the HPV vaccine and child vaccine initiation. Two logistic regressions were run. The
first used pros and the second used cons as the continuous independent variable. The
‘odds ratio’ for pros was 1.06 with a 95% confidence interval of [1.05-1.10], p<.000.
This suggests that for each one unit increase in pros, the child was 6% more likely to
have initiated the vaccine. The range for this scale was 4-20, so participants with a
score of 5 are 6% more likely to have initiated the vaccine compared to participants
with a score of 4.
The ‘odds ratio’ for cons was 1.05 with a 95% confidence interval of [1.021.07], p<.000. This suggests that for each one unit increase in cons, the child was 5%
more likely to have initiated the vaccine (See Table 5). The range for this scale was 420, so participants with a score of 5 are 5% more likely to have initiated the vaccine
compared to participants with a score of 4.

Hypothesis 11: The children of those parents who have more vaccine selfefficacy (i.e., higher confidence) will be more likely to have initiated the vaccine
series, as measured by the Self-efficacy for HPV scale. A logistic regression
analysis was performed to assess the relationship between self-efficacy and child
vaccine initiation. The model contained self-efficacy as the continuous independent
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variable. The ‘odds ratio’ was 1.07 with a 95% confidence interval of [1.04-1.10],
p<.000. This suggests that for each one unit increase in self efficacy, the child was 7%
more likely to have initiated the vaccine (See Table 5). The range for this scale was 630, so participants with a score of 7 are 7% more likely to have initiated the vaccine
compared to participants with a score of 6.
Hypothesis 12: When all significant variables are looked at together, TTM
variables (decisional balance, self-efficacy) will be the strongest predictors of
HPV vaccine initiation. A multivariate logistic regression analysis was performed to
assess of the relationship between the variables that were found to be significant in the
univariate logistic regressions and child vaccine initiation. The model contained seven
independent variables (healthcare provider recommendation, perceived vaccine
effectiveness, perceived harm, barriers to vaccination, pros, cons, and self-efficacy).
As shown in Table 8, three of the independent variables made a unique statistically
significant contribution to the model (healthcare provider recommendation, barriers to
vaccination, and perceived harm to vaccination). The strongest predictor of reporting
vaccine initiation was healthcare provider recommendation, recording an odds ratio of
18.84 and a 95% confidence interval of [8.96-39.63], p<.000. This indicates that
respondents who received a healthcare provider recommendation were over 18 times
more likely to have initiated the vaccine series, controlling for all other factors in the
model. See Table 6.
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Hypothesis 13: TTM measures of decisional balance and self-efficacy will
be validated in a population of male and female parents/caregivers. The eight
items of the Decisional Balance for HPV vaccination scale were subjected to
confirmatory factor analysis (CFA) using structural equation modeling in EQS
software (see Figure 1). Four models were tested: (1) null model (suggesting no latent
factors and used as a comparative model), (2) one factor, (3) two uncorrelated Pros
and Cons factors, and (4) two correlated Pros and Cons factors. The two-factor
correlated model demonstrated the best fit, χ² (19)=66.65, p<.05, CFI= .964,
GFI=.948,RMSEA=.093, and AASR= .045. The correlation between the Pros and
Cons scales was .051.
The six items of the Self-efficacy for HPV vaccination scale were subjected to
CFA (see Figure 2). Two models were tested: the null model and a one-factor model.
The one-factor model demonstrated the best fit, χ² (9)=29.26, p<.05, CFI= ..977,
GFI=.968, RMSEA=.088, and AASR= .020.
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Discussion
The current study examined sociocultural predictors of parents’ and caregivers’
decisions to vaccinate their children against HPV. The study extends previous research
by examining a diverse national sample of parents and caregivers. The data was
census balanced for race/ethnicity and region of origin and male and female
respondents were surveyed about their beliefs about the HPV vaccine as it relates to
both male and female children. It is also one of few studies to compare male and
female parents’ attitudes about HPV vaccination. Most previous studies examining
parents’ attitudes and beliefs surveyed mothers or female caregivers only. Some
attempted to survey both male and female caregivers (Brewer, et al, 2011; Guerry et
al., 2011; Gilkey et al., 2012) but found that most respondents were female (between
88-91%). The current study found that 31.8% of the respondents were male, allowing
for a deeper understanding of male caregivers’ attitudes and the role they play in
deciding to vaccinate their children. Additionally, this is one of few studies to compare
male and female children and contributes to an emerging body of literature reporting
rates of HPV vaccine initiation among young males. Almost 46% of the children
described in the study were male. Finally, this is the first study to examine TTM
variables related to HPV vaccination among parents and caregivers of children and
adolescents that are eligible for the HPV vaccine.
The modal participant identified as a white, heterosexual mother and was
married, had a 4-year degree or higher, had an estimated household income of 75,000
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or higher, was born in the United States, currently living in the northeast, and had two
children. The modal child described by respondents was female, white, and had not
completed the HPV vaccine series. Surprisingly, more male children initiated the
vaccine than female children (54% vs. 46%) though Centers for Disease Control and
Prevention reported that nationally 53% of female adolescents had received at least
one shot and only 21% of male adolescents had received on shot (Centers for Disease
Control and Prevention, 2013).
Sociocultural Predictors
Health care provider recommendation. Consistent with past research
indicating that health care provider recommendation is a strong predictor of HPV
vaccination (Gilkey, Moss, McRee, & Brewer, 2012; Reiter, Brewer, & Smith, 2010;
Reiter, Brewer, McRee et al., 2010; Ylitalo, Lee, Mehta, 2012), health care provider
recommendation was found to be the strongest predictor of vaccine initiation and
respondents who reported that their child received a health care provider
recommendation were 18 times more likely to have initiated. This finding is especially
important as researchers have found that providers are less likely to recommend the
vaccine to boys and racial/ethnic minorities which may contribute to the lower
vaccination rates found among these groups (Gilkey, Moss, MeRee, & Brewer, 2012;
Ylitalo, Lee, Mehta, 2012). These findings highlight the need for more effective
methods to promote vaccination recommendation among health care providers to
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ensure that all demographic groups are receiving the same recommendations and
information.
Race/ethnicity and Socioeconomic Status. Contrary to previous findings
(Mays, Stru, & Zimet, 2004; Jain et al., 2009), race and ethnicity did not predict
vaccine initiation or completion and there were no significant differences found across
race/ethnicity on TTM or CHIAS variables, vaccine initiation or completion, or health
care provider recommendation. In fact, more racial and ethnic minorities had initiated
the vaccine than white respondents (53.4% vs. 48%) and more than half of non-white
respondents’ children had initiated the vaccine.
Perhaps some of the disparities found in previous studies can be better
explained by socioeconomic factors. The current study found that parents with 4-years
of college education or higher reported significantly higher self-efficacy for
vaccinating their child against HPV as compared to parents with less education. In
addition, parents living in households with an annual income of $75,000 or more
reported significantly higher scores for perceived vaccine effectiveness.
Regional differences in vaccine uptake have previously been found. HPV
vaccine coverage was highest in the Northeast and lowest in the South (Centers for
Disease Control and Prevention, 2013). Related to these previous findings, current
respondents living in the West reported significantly more cons for vaccinating their
child followed by the South, Midwest, and Northeast. This is particularly troublesome
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given the increased cervical cancer disparities among women living in low-income
regions with limited healthcare access like the Appalachian South (Katz et al., 2009).
Three primary barriers have been identified for Appalachian women, misinformation
about HPV and the HPV vaccine, tangible barriers, and ambiguous information
sources (Mills, Head, Vanderpool, 2013). In addition, many communities are
experiencing growing numbers of parents who are delaying and/or refusing available
recommended vaccinations for their children (Larson, Jarrett, Eckersberger, Smith, &
Paterson, 2014; Dube, Vivion, & MacDonald, 2015; Dube, Gagnon, Nickels, Jeram,
Schuster, 2014) which may explain why respondents in the West reported more cons
for vaccination.
Taken together, these findings indicate that parents from higher socioeconomic
households feel more confident that they will vaccinate their child for HPV and
perceive the vaccine to be more effective. Conversely, some parents may be a part of
the “anti-vaccine movement” and see many more cons to vaccination than others and
the reasons for this are often complex and context-specific (Larson, Jarrett,
Eckersberger, Smith, & Paterson, 2014). Health care providers should use clear and
purposeful communication about the development of HPV related cancers and the
purpose and safety of the vaccine. Additionally, marketing and social marketing
practices may be used to foster vaccine acceptance (Nowak, Gellin, MacDonald, &
Butler, 2015).
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Gender. Based on previous findings (Linddon, Hood, Wynn, and Markowitz,
2010; Centers for Disease Control, 2013), it was hypothesized that male children
would be less likely to have initiated the vaccine, however, gender did not predict
vaccine initiation or completion. While gender was not predictive of vaccine uptake,
exploratory analyses found differences that were similar to previous findings
(Berenson & Rahman, 2012; Gilkey, Moss, McRee, & Brewer, 2012). There were
significant differences between parent’s attitudes and beliefs about vaccinating male
vs. female children. Parents and caregivers indicated that they had more cons,
perceived more harm, and perceived more barriers for vaccinating male children as
compared to female children. Female children also appeared to receive a larger percent
of health care provider recommendations to vaccinate as compared to male children
(56% vs. 43.6%). Despite these differences, 54% of male children in the study had
initiated the vaccine and 38% had completed the vaccine series. This may partially be
explained by the slight increase in HPV vaccine uptake among males in recent years
(Pierre-Victor, Mukherjee, Bahelah, & Madhivanan, 2014) and the implementation of
the Patient Protection and Affordable Care Act of 2010 (Centers for Disease
Prevention and Control, 2013).
Additionally, there were significant differences found between parents’ gender
and vaccine initiation/completion. While male parents reported more uncertainty about
vaccinating their children, they reported that more of their children had initiated the
vaccine and completed the vaccine as compared to female respondents (59% vs. 45%;
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44% vs. 31%). It is difficult to hypothesize about this finding given the dearth of
research in this area. Most studies examining parents’ decisions to vaccinate their
children include very little information about male parents’ perspectives (May, Sturm,
& Zimet, 2004; Downs, de Bruin, & Fishhoff, 2008; Trim, Nagji, Elit, & Roy, 2011).
Parent-child Communication. Parents who talked to their children about
HPV vaccination were almost three times more likely to have also talked to them
about safe sex practices. Many parents rely on situations that arise spontaneously to
prompt conversations with their children about safe sex (Rosenthal, Feldman, &
Edwards, 1998; O’Sullivan, Meyer-Bahlburg, & Watkins, 2001). These findings
suggest that discussions about the vaccine may provide parents with an opportunity to
talk with their children about STIs and the importance of safe sex. Perhaps health care
providers could use HPV vaccine recommendation as a cue to talk to parents about
using the vaccine to prompt a conversation about safe sex as parent-child
communication about sex is associated with decreased sexual risk taking during
adolescence and an older age at sexual debut (DeClemente et al., 2001; Miller et al.,
1998).
CHIAS Predictors
As hypothesized, perceived effectiveness and perceived harm predicted
vaccine initiation. The results indicated that as the respondents’ perceived
effectiveness increased, the likelihood that their child had initiated the vaccine
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increased. As the respondents’ perceived harm increased, the likelihood that their child
had initiated the vaccine decreased. Interestingly, as respondents’ perceived barriers
increased, the likelihood that their child had initiated the vaccine increased.
Respondents’ mean score on effectiveness was higher than their mean score on
barriers. Perhaps these parents’ high level of perceived vaccine effectiveness helped
them to overcome the perceived barriers. Additionally, most questions on the barriers
subscale addressed vaccine affordability and availability. Implementation of the
Patient Protection and Affordable Care Act of 2010 now requires private health care
plans to offer, at no cost to beneficiaries, vaccines recommended by ACIP (Centers for
Disease Prevention and Control, 2013), these changes could have helped respondents
to overcome some barriers and initiate vaccination.
Previously, health care providers reported that parental beliefs, perceptions,
and misconceptions about the vaccine acted as barriers to HPV vaccination in a clinic
serving a predominantly Hispanic population (Javanbakht et al., 2012). Taken
together, these findings highlight the importance of providing parents with accurate
information about vaccine harm and effectiveness. Vaccine misconceptions could be
addressed with education about the need for child and adolescent vaccines, the safety
of the vaccine, and availability of the vaccine.
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TTM Predictors
As hypothesized, the TTM variables (decisional balance and self-efficacy)
were predictors of vaccine initiation. The results indicated that as the number of pros
increased, the likelihood of vaccine initiation increased. As respondents reported
greater self-efficacy for vaccination, the likelihood of vaccine initiation increased.
Surprisingly, as the number of cons increased, the likelihood of vaccine initiation also
increased. Respondents indicated a large number of both pros and cons, but overall
they reported more pros. Literature on other health behaviors supports the importance
of pros on health behavior decision making. Part of the decision to move towards
action/maintenance (initiation of the vaccine and ultimately completion of all three
shots) is based on the relative weight given to the pros and cons of making a
behavioral change. Pros may be thought of as facilitators of change (Prochaska, et al.,
1994) which would explain why respondents weighing more pros for vaccination
would be more likely to have made a behavioral change (initiating the vaccine).
Alternatively, it is possible that the cross-sectional design of the study limited our
assessment of the relationship between pros and vaccine completion. Many of the
respondents reported that their child had already started the vaccine series. Vaccine
initiation could be impacting the parent’s rating of their pros and cons for vaccination.
As hypothesized, the TTM measures for decisional balance and self-efficacy
for HPV vaccination were validated in a sample of parents and caregivers. This adds
three new TTM-based measures to the literature. These measures can be used to
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understand behavior change among parents of children that are eligible to receive the
HPV vaccine and will promote vaccination research.
Limitations
There are several limitations to this study that should be considered. Parents
and caregivers reported their child’s vaccination status, leaving room for errors in
reporting. It is possible that their child’s other parent or guardian is responsible for
taking them to see their health care provider and that they might have more accurate
information about their child’s vaccination status. The results are based on a
convenience sample as 71.2% of the respondents used SSI to complete the survey and
28.8% were recruited informally (via emailing the survey to colleagues). Participants
recruited though SSI earn points for completing surveys and exchange them for small
prizes. Although the sample was reflective of the racial/ethnic and regional breakdown
of the United States, participants that are willing and able to commit time to
completing online surveys may have unique characteristics. For example, the sample
was not diverse in terms of socioeconomic status as almost half of the respondents
reported an annual household income of $75,000 of greater and over half had earned a
4-year degree or higher. Given this homogeneity, the relationship between
socioeconomic status and vaccine initiation was unable to be fully explored. Future
research will be required to determine generalizability.
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Future Directions
Notwithstanding these warnings, this study provides a number of meaningful
conclusions that will help further investigation of HPV vaccine behaviors among
children and adolescents. Low adherence to vaccine recommendation is an issue of
major public health concern. To our knowledge, this is the first study to validate TTM
measures for HPV vaccination with a sample of parents and caregivers. It is also the
first study to examine sociocultural characteristics and TTM variables as they relate to
both male and female parents’ decisions to vaccinate their children against HPV.
Given that pros, self-efficacy, and perceived effectiveness were found to be predictive
of vaccine initiation, these variable appear to make a difference in whether a parent
chooses to vaccinate their child. However, the respondents’ pros, self-efficacy, and
perceived effectiveness may have increased following vaccine initiation. A
longitudinal design would be helpful in determining whether these variables predict
vaccine initiation or if vaccine initiation predict an increase in those variables.
These findings may inform future TTM-tailored interventions aimed at
increasing HPV vaccine initiation among children and adolescents. Further,
population-based approaches to increasing HPV vaccination may be possible and are
likely to have the most impact on reducing rates of HPV related cancers. Previous
research has illustrated the utility of tailored approaches to interventions that can be
provided on a population basis (Krebs, Prochaska, & Rossi, 2010). Future studies
should also assist in developing tailored approaches to interventions for both health
39

care providers and parents and caregivers. Future work should examine ways to ensure
that health care providers are providing equivalent information about vaccination to all
patients regardless of race/ethnicity, gender, and socioeconomic status. Additionally,
researchers should examine ways to increase parents’ pros, self-efficacy, and
perceived effectiveness for HPV vaccination for sons as well as daughters.
Conclusions
The current study examined sociocultural predictors of parents’ and caregivers’
decisions to vaccinate their children against HPV. Health care provider
recommendation, perceived vaccine effectiveness, pros for vaccination, and selfefficacy increased the likelihood that children had initiated the HPV vaccine. While no
significant differences were found for race/ethnicity and gender on vaccine initiation,
some disparities were noted. There were regional differences in perceived cons for
vaccination, socioeconomic differences in self-efficacy and perceived effectiveness,
and gender differences in health care provider recommendation and parent perception
of cons, vaccine harm, and barriers. These findings may inform future, tailored
interventions aimed at increasing HPV vaccine initiation among children and
adolescents.
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Table 1. Demographics
Parent Demographics
%

N

White

69.9

204

Latino/Latina

11.6

34

Black/African American

11

32

Asian

4.8

14

American Indian

1.4

4

Native Hawaiian or Pacific Islander

0.3

1

Other

1

3

Mother

63

184

Father

28.4

83

Female Guardian or Caregiver

5.1

15

Male Guardian or Caregiver
Parent Sexual Orientation
Heterosexual

3.4

10

93.5

273

Lesbian or Gay

1.4

4

Bisexual

3.8

11

Pansexual

0.3

1

1

3

Married

77.4

226

In a Relationship and Living with Partner

6.2

18

In a Relationship and not Living with Partner

0.7

2

Single, Never Married

7.9

23

Divorced

4.8

14

Separated

1

3

Widowed

1.4

4

Domestic Partnership

0.7

2

Four Years of Higher

52.7

154

Some College

35.6

104

HS Diploma/GED or Below

11.6

34

Under 25,000

9.1
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Parent Race/Ethnicity

Parent Status

Prefer not to Answer
Marital Status

Parent Education

Household Income

41

25,000-50,000

18.9

54

50,000-75,000

22.1

63

75,000 or More

45.9

134

Choose not to Answer

2.7

8

Parent Demographics Continued
%

N

South

30.1

88

Northeast

35.1

103

Midwest

21.6

63

13

38

1

61

20.9

2

111

38

3

69

23.6

4

32

11

5

14

4.8

More than 5

5

1.7

Geographic Region

West
Number of Children

Child Demographics
Child Race/Ethnicity
White

194

66.4

Latino/Latina

31

10.6

Black/African American

34

11.6

Asian

12

4.1

American Indian

3

1

Native Hawaiian or Pacific Islander

2

0.7

Other

16

5.5

Female

158

54.3

Male

133

45.7

103

35.3

No

189

64.7

Yes

145

49.7

No

147

50.3

Child Gender

Child Vaccination Status
Completed Vaccine Series
Yes

Initiated Vaccine Series (One or More Shots)

Healthcare Provider Recommended Vaccine

42

Yes

147

50.3

No

126

43.2

Don’t Know

19

6.5

43

Table 2 Descriptive Statistics and Cronbach’s Alpha for Measures

Measure

# of
items

M

SD

Possible
range

Alpha

4
4
6

4.03
2.16
3.23

0.98
1.25
1.08

4-20
4-20
6-30

0.86
0.88
0.89

6
5
2
3

2.47
1.79
2.62
2.57

0.76
0.88
0.83
0.7

6-24
5-20
2-8
3-12

0.84
0.92
0.83
0.45

TTM Variables
Pros
Cons
Self-efficacy
CHIAS Variables
Perceived Harm
Barriers
Effectiveness
Uncertainty
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Table 3 Race and Gender by TTM & CHIAS variables
White

Parent Race
M

Pros
Cons
Self-efficacy
Perceived Harm
Barriers
Effectiveness
Uncertainty
Child Gender

46.64
10.17
49.61
10.3
50.51
10.33
50.22
10.32
49.77
10.48
50.26
10.34
50.6
10.12
Female
M

Pros
Cons
Self-efficacy
Perceived Harm
Barriers
Effectiveness
Uncertainty
Parent Gender
Pros
Cons
Self-efficacy
Perceived harm
Barriers
Effectiveness
Uncertainty

Non-White
SD

SD

M

SD

50.82
50.91
48.82
49.48
50.52
49.4
48.66

9.61
9.26
9.11
9.24
8.82
9.21
9.65
Male

M

49.2
10.44
47.85
8.83
49.11
10.06
48.85
9.58
47.89
8.69
48.66
10.48
49.84
10.29
Female
M
SD
50.35
10.29
47.3
8.73
49.51
10.7
48.32
9.98
46.78
8.17
49.3
10.17
48.82
9.76
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50.87
52.48
51.07
51.24
52.51
51.73
50.14

t

p

-0.93
-1.02
1.33
0.58
0.67
0.67
1.5

0.36
0.31
0.18
0.56
0.5
0.5
0.13

t

p

-1.42
-4.04
-1.66
-2.04
-4.01
-2.64
-0.25

0.16
.000**
0.09
.04*
.000**
.009*
0.8

t

p

0.86
-7.35
-1.23
-4.32
-9.06
-1.75
-2.98

0.38
.000**
0.22
.000**
.000**
0.08
.003*

SD

9.4
10.73
9.89
10.31
10.89
9.04
9.71
Male
M
SD
49.26
9.37
55.78
10.13
51.05
8.26
53.59
9.08
56.85
10.12
51.49
9.51
52.51
10.1

Table 4 Parent Education, Geographic Region, and Household income by TTM & CHIAS variables
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Table 5. Univariate Logistic Regression Results

Odds Ratio
HPV Variables
Health care recommendation
Talked about HPV
vaccination
Demographics
Race
Ethnicity
Child Gender
CHIAS measures
Effectiveness
Perceived harm
Barriers
Uncertainty
TTM measures
Pros
Cons
Self-efficacy

95% C.I.
Lower Upper

Sig.

11.73

6.63

20.75

.000**

2.90

1.90

4.42

.000**

1.24
1.16
1.37

0.75
0.57
0.85

2.05
2.38
2.18

0.40
0.68
0.18

1.08
0.96
1.04
0.97

1.05
0.94
1.02
0.95

1.11
0.98
1.06
1.00

.000**
.001**
.003*
0.08

1.08
1.05
1.07

1.05
1.02
1.04

1.10
1.07
1.10

.000**
.000**
.000**
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Table 6. Multivariate Logistic Regression Results

Odds Ratio
HPV Variables
Health care recommendation
CHIAS measures
Effectiveness
Perceived harm
Barriers
TTM measures
Pros
Cons
Self-efficacy

95% C.I.
Lower Upper

Sig.

18.84

8.96

39.63

.000**

1.04
0.91
1.08

0.99
0.86
1.03

1.09
0.96
1.15

0.06
.000**
.003*

1.04
1.04
1.03

0.99
0.98
0.98

1.08
1.09
1.06

0.08
0.13
0.22
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Figure 1 CFA Decisional Balance model
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Figure 2 CFA Self-efficacy model
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